Table 2.
Fluochrome labeling | Sham | C | E | ALN | ||||
---|---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
Total callus ventromedial (Tt.Cl.v) (mm2) | 0.95 | ±0.53 | 0.71 | ±0.35 | 1.01 | ±0.45 | 0.61• | ±0.39 |
CG callus area ventromedial (Cl.Ar.v) (mm2) | 0.25 | ±0.26 | 0.16 | ±0.12 | 0.39∆ | ±0.28 | 0.14• | ±0.17 |
AK callus area ventromedial (Cl.Ar.v) (mm2) | 0.09 | ±0.11 | 0.06 | ±0.05 | 0.1 | ±0.07 | 0.1 | ±0.09 |
TC callus area ventromedial (Cl.Ar.v) (mm2) | 0.27 | ±0.27 | 0.13 | ±0.12 | 0.14 | ±0.14 | 0.11* | ±0.11 |
Total callus dorsal (Tt.Cl.d) (mm2) | 1.61 | ±0.74 | 1.52 | ±0.1 | 1.4 | ±0.56 | 1.3 | ±0.76 |
CG callus area dorsal (Cl.Ar.d) (mm2) | 0.5 | ±0.21 | 0.43 | ±0.39 | 0.54 | ±0.23 | 0.52 | ±0.37 |
AK callus area dorsal (Cl.Ar.d) (mm2) | 0.21 | ±0.27 | 0.17 | ±0.2 | 0.11 | ±0.06 | 0.16 | ±0.11 |
TC callus area dorsal (Cl.Ar.d) (mm2) | 0.41 | ±0.29 | 0.22 | ±0.23 | 0.33 | ±0.38 | 0.2 | ±0.23 |
Total callus endosteal (Tt.Cl.e) (mm2) | 1.12 | ±0.7 | 1.21 | ±0.8 | 1.28 | ±0.73 | 1.15 | ±0.52 |
CG callus area endosteal (Cl.Ar.e) (mm2) | 0.35 | ±0.29 | 0.14 | ±0.15 | 0.34 | ±0.23 | 0.35∆ | ±0.26 |
AK callus area endosteal (Cl.Ar.e) (mm2) | 0.09 | ±0.08 | 0.14 | ±0.12 | 0.2 | ±0.16 | 0.2 | ±0.16 |
TC callus area endosteal (Cl.Ar.e) (mm2) | 0.34 | ±0.36 | 0.41 | ±0.26 | 0.3 | ±0.32 | 0.2 | ±0.22 |
C osteoporotic C, E estrogen, ALN alendronate
aAverage value ± SD of the mean. P values of <0.05 were considered to be significant (* P < 0.05 vs. sham group, ∆ P < 0.05 vs. C group, • P < 0.05 vs. E group)